Assessment of Neuron-Specific Enolase and Brain-Derived Neurotrophic Factor Levels at Rehabilitation Stages in the Early and Late Recovery Periods of Ischemic Stroke-Reference-Cited by-同舟云学术

Assessment of Neuron-Specific Enolase and Brain-Derived Neurotrophic Factor Levels at Rehabilitation Stages in the Early and Late Recovery Periods of Ischemic Stroke

Published:2021-06 Issue:5 Volume:51 Page:570-576
ISSN:0097-0549
Container-title:Neuroscience and Behavioral Physiology
language:en
Short-container-title:Neurosci Behav Physi

Author:

Koroleva E. S.,Brazovskaya N. G.,Levchuk L. A.,Kazakov S. D.,Romadina N. Yu.,Alifirova V. M.

Publisher

Springer Science and Business Media LLC

Subject

General Neuroscience

Link

https://link.springer.com/content/pdf/10.1007/s11055-021-01107-0.pdf

Reference17 articles.

1. W. Whiteley, “Identifying blood biomarkers to improve the diagnosis of stroke,” J. R. Coll. Physicians Edinb., 41, No. 2, 152–154 (2011), https://doi.org/10.4997/jrcpe.2011.207.

2. G. C. Jickling and F. R. Sharp, “Blood biomarkers of ischemic stroke,” Neurotherapeutics, 8, 349–360 (2011), https://doi.org/10.1007/s13311-011-0050-4.

3. S. González-García, A. González-Quevedo, M. Peña-Sánchez, et al., “Serum neuron specific enolase and S100 calcium binding protein B biomarker levels do not improve diagnosis of acute stroke,” J. R. Coll. Physicians Edinb., 42, 199–204 (2012), https://doi.org/10.4997/JRCPE.2012.302.

4. S. González-García, A. González-Quevedo, O. Fernández-Concepción, et al., “Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients,” Clin. Biochem., 45, No. 16–17, 1302–1307 (2012), https://doi.org/10.1016/j.clinbiochem.2012.07.094.

5. A. Gójska-Grymajło, M. Zieliński, A. Wardowska, et al., “CXCR7+ and CXCR4+ stem cells and neuron specifi c enolase in acute ischemic stroke patients,” Neurochem. Int., 120, 134–139 (2018), https://doi.org/10.1016/j.neuint.2018.08.009.